Lamdong Pharmaceutical Joint Stock Company reported earnings results for the fourth quarter ended December 31, 2022. For the fourth quarter, the company reported revenue was VND 49,045.76 million compared to VND 42,399.59 million a year ago. Net loss was VND 11,561.51 million compared to net income of VND 55,403.45 million a year ago.

Basic loss per share from continuing operations was VND 910 compared to basic earnings per share from continuing operations of VND 4,361 a year ago. Diluted loss per share from continuing operations was VND 910 compared to diluted earnings per share from continuing operations of VND 4,361 a year ago.